SNX
SNX: Thompson Reyna discloses a sale
Thompson Reyna reported Sale in TD SYNNEX CORP: 200 units of Common Stock, dated 2026-10-20. The full Form 4 contains 6 transaction entries.
LoadingLoadingLoadingSNX
Thompson Reyna reported Sale in TD SYNNEX CORP: 200 units of Common Stock, dated 2026-10-20. The full Form 4 contains 6 transaction entries.
GTLB
Sijbrandij Sytse reported Sale in Gitlab Inc.: 73459 units of Class A Common Stock, dated 2026-10-19. The full Form 4 contains 2 transaction entries.
PETV
A.L. Sarroff Fund, LLC reported Purchase in PetVivo Holdings, Inc.: 9000 units of Common Stock, dated 2026-10-13. The full Form 4 contains 14 transaction entries.
XYL
Emmerich Meredith reported Tax/exercise withholding in Xylem Inc.: 837 units of Common Stock, dated 2026-10-21. The full Form 4 contains 1 transaction entry.
CARG
Mandel Matthew Charles reported 175,083 shares of Class A Common Stock in CarGurus, Inc. as grants or awards dated 2026-10-19. The Form 4 was disclosed on Oct 21, 2026. These were stock awards, not open-market purchases.
STRR
Eberwein Jeffrey E. reported Sale in Star Equity Holdings, Inc.: 1000 units of Series A Preferred Stock, dated 2026-10-19. The full Form 4 contains 3 transaction entries.
DSM
Saba Capital Management, L.P. reported Purchase in BNY MELLON STRATEGIC MUNICIPAL BOND FUND, INC.: 14573 units of Common Stock, dated 2026-10-20. The full Form 4 contains 1 transaction entry.
NTRS
Qureshi Rima reported 495 shares of Common Stock in NORTHERN TRUST CORP as grants or awards dated 2026-10-20. The Form 4 was disclosed on Oct 21, 2026. These were stock awards, not open-market purchases.
HQ
Fitzsimons Catherine Michele reported Grant or award in Horizon Quantum Holdings Ltd.: 601932 units of Stock Option (Right to Buy) (derivative), dated 2026-06-11. The full Form 4 contains 1 transaction entry.
DNA
Kelly Jason R reported Exercise or conversion in Ginkgo Bioworks Holdings, Inc.: 55694 units of Class A Common Stock, dated 2026-10-16. The full Form 4 contains 5 transaction entries.
DNA
Shetty Reshma P. reported Exercise or conversion in Ginkgo Bioworks Holdings, Inc.: 29279 units of Class A Common Stock, dated 2026-10-16. The full Form 4 contains 10 transaction entries.
DNA
Canton Barry reported Exercise or conversion in Ginkgo Bioworks Holdings, Inc.: 26802 units of Class A Common Stock, dated 2026-10-16. The full Form 4 contains 10 transaction entries.
DNA
Coen Steven P. reported Exercise or conversion in Ginkgo Bioworks Holdings, Inc.: 1174 units of Class A Common Stock, dated 2026-10-16. The full Form 4 contains 5 transaction entries.
INTA
HALL JOHN T reported Exercise or conversion in Intapp, Inc.: 3000 units of Common Stock, dated 2026-10-19. The full Form 4 contains 4 transaction entries.
VRXA
Ziegler Christoph Samuel reported Purchase in Veraxa Biotech AG - Post de-SPAC: 30000 units of Ordinary Shares, dated 2026-10-20. The full Form 4 contains 1 transaction entry.
IKT
Wasserman Scott M. reported Grant or award in Inhibikase Therapeutics, Inc.: 310000 units of Stock Option (Right to Buy) (derivative), dated 2026-10-19. The full Form 4 contains 1 transaction entry.
WS
Larivey Clifford reported Sale in Worthington Steel, Inc.: 6868 units of Common Shares, dated 2026-10-19. The full Form 4 contains 2 transaction entries.
LEO
Saba Capital Management, L.P. reported Purchase in BNY MELLON STRATEGIC MUNICIPALS, INC.: 7724 units of Common Stock, dated 2026-10-20. The full Form 4 contains 1 transaction entry.
NBIS
Grimme Arne reported Purchase in Nebius Group N.V.: 151 units of Class A Shares, dated 2026-10-20. The full Form 4 contains 2 transaction entries.
DRCT
Diaz Diana P reported Exercise or conversion in Direct Digital Holdings, Inc.: 28 units of Class A Common Stock, par value $0.001 per share, dated 2026-10-16. The full Form 4 contains 3 transaction entries.
FRBT
Sachs Lewis A reported Disposition to issuer in Forbright, Inc.: 148256 units of Class B Common Stock, dated 2026-10-19. The full Form 4 contains 2 transaction entries.
BENF
Wendel Karen reported 25,689 shares of Class A Common Stock in Beneficient as grants or awards dated 2026-09-30. The Form 4 was disclosed on Oct 21, 2026. These were stock awards, not open-market purchases.
CLNN
Etherington Robert Dee reported Grant or award in Clene Inc.: 55000 units of stock option (derivative), dated 2026-10-20. The full Form 4 contains 1 transaction entry.
CLNN
BROWN MORGAN R reported Grant or award in Clene Inc.: 20000 units of stock option (derivative), dated 2026-10-20. The full Form 4 contains 1 transaction entry.
